Azole antifungals as novel chemotherapeutic agents against murine tuberculosis. 2006

Zahoor Ahmad, and Sadhna Sharma, and G K Khuller
Department of Biochemistry, Postgraduate Institute of Medical Education & Research, Chandigarh, India.

The present study was designed to evaluate the in vivo antimycobacterial potential of econazole alone and in combination with antitubercular drugs against tuberculosis in mice. Econazole was found to reduce bacterial burden by 90% in the lungs and spleen of mice infected with 1 x 10(7) cells of Mycobacterium tuberculosis and was found to be equipotent to rifampicin. Further, our results indicate that econazole can replace rifampicin/isoniazid as well as both rifampicin and isoniazid in chemotherapy of murine tuberculosis. Econazole alone or in combination with antitubercular drugs did not produce any hepatotoxicity in normal or M. tuberculosis-infected mice.

UI MeSH Term Description Entries
D008297 Male Males
D009169 Mycobacterium tuberculosis A species of gram-positive, aerobic bacteria that produces TUBERCULOSIS in humans, other primates, CATTLE; DOGS; and some other animals which have contact with humans. Growth tends to be in serpentine, cordlike masses in which the bacilli show a parallel orientation. Mycobacterium tuberculosis H37Rv
D004359 Drug Therapy, Combination Therapy with two or more separate preparations given for a combined effect. Combination Chemotherapy,Polychemotherapy,Chemotherapy, Combination,Combination Drug Therapy,Drug Polytherapy,Therapy, Combination Drug,Chemotherapies, Combination,Combination Chemotherapies,Combination Drug Therapies,Drug Polytherapies,Drug Therapies, Combination,Polychemotherapies,Polytherapies, Drug,Polytherapy, Drug,Therapies, Combination Drug
D004464 Econazole An imidazole derivative that is commonly used as a topical antifungal agent. Econazole Nitrate,Ekonazole,Gyno-Pervaryl 150,Gyno-Pevaril,Gyno-Pevaryl,Pevaryl,Gyno Pervaryl 150,Gyno Pevaril,Gyno Pevaryl,GynoPevaril,Nitrate, Econazole
D005260 Female Females
D000818 Animals Unicellular or multicellular, heterotrophic organisms, that have sensation and the power of voluntary movement. Under the older five kingdom paradigm, Animalia was one of the kingdoms. Under the modern three domain model, Animalia represents one of the many groups in the domain EUKARYOTA. Animal,Metazoa,Animalia
D000904 Antibiotics, Antitubercular Substances obtained from various species of microorganisms that are, alone or in combination with other agents, of use in treating various forms of tuberculosis; most of these agents are merely bacteriostatic, induce resistance in the organisms, and may be toxic. Antitubercular Antibiotics
D000935 Antifungal Agents Substances that destroy fungi by suppressing their ability to grow or reproduce. They differ from FUNGICIDES, INDUSTRIAL because they defend against fungi present in human or animal tissues. Anti-Fungal Agents,Antifungal Agent,Fungicides, Therapeutic,Antibiotics, Antifungal,Therapeutic Fungicides,Agent, Antifungal,Anti Fungal Agents,Antifungal Antibiotics
D000995 Antitubercular Agents Drugs used in the treatment of tuberculosis. They are divided into two main classes: "first-line" agents, those with the greatest efficacy and acceptable degrees of toxicity used successfully in the great majority of cases; and "second-line" drugs used in drug-resistant cases or those in which some other patient-related condition has compromised the effectiveness of primary therapy. Anti-Tuberculosis Agent,Anti-Tuberculosis Agents,Anti-Tuberculosis Drug,Anti-Tuberculosis Drugs,Antitubercular Agent,Antitubercular Drug,Tuberculostatic Agent,Tuberculostatic Agents,Antitubercular Drugs,Agent, Anti-Tuberculosis,Agent, Antitubercular,Agent, Tuberculostatic,Anti Tuberculosis Agent,Anti Tuberculosis Agents,Anti Tuberculosis Drug,Anti Tuberculosis Drugs,Drug, Anti-Tuberculosis,Drug, Antitubercular
D014376 Tuberculosis Any of the infectious diseases of man and other animals caused by species of MYCOBACTERIUM TUBERCULOSIS. Koch's Disease,Kochs Disease,Mycobacterium tuberculosis Infection,Infection, Mycobacterium tuberculosis,Infections, Mycobacterium tuberculosis,Koch Disease,Mycobacterium tuberculosis Infections,Tuberculoses

Related Publications

Zahoor Ahmad, and Sadhna Sharma, and G K Khuller
January 1989, Clinics in dermatology,
Zahoor Ahmad, and Sadhna Sharma, and G K Khuller
January 2006, Therapie,
Zahoor Ahmad, and Sadhna Sharma, and G K Khuller
February 2005, Expert opinion on emerging drugs,
Zahoor Ahmad, and Sadhna Sharma, and G K Khuller
April 2008, Seminars in respiratory and critical care medicine,
Zahoor Ahmad, and Sadhna Sharma, and G K Khuller
December 1987, The Journal of urology,
Zahoor Ahmad, and Sadhna Sharma, and G K Khuller
November 2003, International journal of cancer,
Zahoor Ahmad, and Sadhna Sharma, and G K Khuller
September 2013, ACS medicinal chemistry letters,
Zahoor Ahmad, and Sadhna Sharma, and G K Khuller
January 2021, Current pharmaceutical design,
Zahoor Ahmad, and Sadhna Sharma, and G K Khuller
July 2011, Journal of controlled release : official journal of the Controlled Release Society,
Zahoor Ahmad, and Sadhna Sharma, and G K Khuller
August 1990, Journal of steroid biochemistry,
Copied contents to your clipboard!